Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome accompanied by Parkinson's disease.
We encountered two cases of RS3PE (remitting seronegative symmetrical synovitis with pitting edema) syndrome accompanied by Parkinson's disease (PD). Although the etiology of RS3PE syndrome is still unknown, several possible associations, such as malignancies and viral infections, have been reported; RS3PE syndrome is thought to be an autoimmune-mediated disorder. The present patients did not have any factors which are reported to be associated with RS3PE. Whether or not the complication of PD and RS3PE syndrome is incidental needs to be further examined, and we discuss here the possible cause of association between PD and RS3PE syndrome, including dopamine agonists one of the anti-PD medications.
Ito
Eiichi
E
Department of Neurology, Neurological Institute, Tokyo Women's Medical University.
Okamoto
Hiroshi
H
Mochizuki
Atsuko
A
Ohara
Kuniko
K
Kato
Maiko
M
Terashima
Yutaka
Y
Tanaka
Eiichi
E
Takagi
Kae
K
Uchiyama
Shinichiro
S
Iwata
Makoto
M
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D003937:Diagnosis, Differential; D004487:Edema / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005528:Foot; D006225:Hand; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D013577:Syndrome; D013585:Synovitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D011239:Prednisolone